◆英語タイトル:PharmAust Ltd (PAA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014337
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月22日
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
PharmAust Ltd (PharmAust) is a drug discovery and development company which provides human and veterinary proprietary medicines to treat different types of cancers. The company provides specialized medicinal and synthetic chemistry services. It specializes in bio defense and laboratory support with synthetic and analytical technologies. PharmAust develops its own drug discovery intellectual property and developed an anticancer product. It undertakes clinical trials of several products. The company collaborates with various pharmaceutical products to develop new products. It markets its products through its distribution network. PharmAust is headquartered in Claremont, Western Australia, Australia.
PharmAust Ltd (PAA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PharmAust Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PharmAust Ltd, Medical Devices Deals, 2011 to YTD 2017 9
PharmAust Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
PharmAust Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Pitney Pharma Enters into Agreement with NewSouth Innovations 11
Licensing Agreements 12
PharmAust Enters into Licensing Agreement with NewSouth Innovations 12
Equity Offering 13
PharmAust Raises Additional Funds in Rights Offering of Shares 13
PharmAust Raises Additional USD1.2 Million in Rights Offering of Shares 15
PharmAust Raises Funds through Rights Offering of Shares 16
PharmAust Raises USD2.4 Million in Private Placement of Shares 17
PharmAust Completes Private Placement Of Shares For US$0.8 Million 18
PharmAust Completes Private Placement Of Shares For US$0.2 Million 19
PharmAust Completes Private Placement Of Shares For US$4.5 Million 20
PharmAust Completes Private Placement Of Shares For US$2.3 Million 21
PharmAust Completes Private Placement Of Shares For US$0.52 Million 22
PharmAust Completes Private Placement Of US$0.65 Million 23
Acquisition 24
PharmAust Completes Acquisition Of Pitney Pharma, Cancer Drug Platforms Developer 24
Epichem Acquires Additional 11% Stake In Its Joint Venture With Curtin University of Technology 25
PharmAust Ltd – Key Competitors 26
PharmAust Ltd – Key Employees 27
PharmAust Ltd – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Corporate Communications 29
Mar 08, 2017: Dr Richard Mollard appointed as Chief Scientific Officer of PharmAust 29
Mar 01, 2017: Dr Richard Hopkins Appointed as CEO of PharmAust 30
Government and Public Interest 31
Jun 16, 2016: Epichem Successful in AusTrade Grant 31
Feb 01, 2016: Pharmaust Receives $546K R&D Rebate From Australian Taxation Office 32
Product News 33
01/29/2016: PharmAust Limited Announced Quarterly Report & Company Update For the period ended 31 December 2015 33
Other Significant Developments 34
Apr 13, 2017: PharmAust: Quarterly Report & Company Update for the period ended 31 March 2017 34
Jan 31, 2017: PharmAust: Quarterly Report & Company Update for the period ended 31 December 2016 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List of Tables
PharmAust Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PharmAust Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PharmAust Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
PharmAust Ltd, Medical Devices Deals, 2011 to YTD 2017 9
PharmAust Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Pitney Pharma Enters into Agreement with NewSouth Innovations 11
PharmAust Enters into Licensing Agreement with NewSouth Innovations 12
PharmAust Raises Additional Funds in Rights Offering of Shares 13
PharmAust Raises Additional USD1.2 Million in Rights Offering of Shares 15
PharmAust Raises Funds through Rights Offering of Shares 16
PharmAust Raises USD2.4 Million in Private Placement of Shares 17
PharmAust Completes Private Placement Of Shares For US$0.8 Million 18
PharmAust Completes Private Placement Of Shares For US$0.2 Million 19
PharmAust Completes Private Placement Of Shares For US$4.5 Million 20
PharmAust Completes Private Placement Of Shares For US$2.3 Million 21
PharmAust Completes Private Placement Of Shares For US$0.52 Million 22
PharmAust Completes Private Placement Of US$0.65 Million 23
PharmAust Completes Acquisition Of Pitney Pharma, Cancer Drug Platforms Developer 24
Epichem Acquires Additional 11% Stake In Its Joint Venture With Curtin University of Technology 25
PharmAust Ltd, Key Competitors 26
PharmAust Ltd, Key Employees 27
PharmAust Ltd, Other Locations 28
PharmAust Ltd, Subsidiaries 28